Skip to main content
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
13.12
+0.62 (4.96%)
At close: Mar 4, 2026, 4:00 PM EST
13.00
-0.12 (-0.91%)
Pre-market: Mar 5, 2026, 8:57 AM EST

Schrödinger Revenue by Type
Period Ending Dec 31, 2025Dec 31, 2025Dec 31, 2025Sep 30, 2025Sep 30, 2025Sep 30, 2025Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Software Products and Services
199.50M 199.50M 199.50M 209.92M 209.92M 209.92M 200.94M 200.94M 200.94M 195.80M 195.80M 195.80M 180.40M 180.40M 180.40M 169.40M 169.40M 169.40M 166.42M 166.42M 166.42M 160.37M 160.37M 160.37M
Software Products and Services Growth
10.59% 10.59% 10.59% 23.92% 23.92% 23.92% 20.74% 20.74% 20.74% 22.09% 22.09% 22.09% 13.34% 13.34% 13.34% 22.52% 22.52% 22.52% 24.17% 24.17% 24.17% 19.07% 19.07% 19.07%
Drug Discovery
56.37M 56.37M 56.37M 47.12M 47.12M 47.12M 37.06M 37.06M 37.06M 34.77M 34.77M 34.77M 27.22M 27.22M 27.22M 24.02M 24.02M 24.02M 34.28M 34.28M 34.28M 28.19M 28.19M 28.19M
Drug Discovery Growth
107.09% 107.09% 107.09% 96.16% 96.16% 96.16% 8.10% 8.10% 8.10% 23.37% 23.37% 23.37% -52.72% -52.72% -52.72% -60.67% -60.67% -60.67% -42.60% -42.60% -42.60% -54.79% -54.79% -54.79%

Software Products and Services Revenue Breakdown
Period Ending Dec 31, 2025Dec 31, 2025Dec 31, 2025Sep 30, 2025Sep 30, 2025Sep 30, 2025Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022Sep 30, 2022Sep 30, 2022Sep 30, 2022Jun 30, 2022Jun 30, 2022Jun 30, 2022
Software Products and Services
27.51M 27.51M 27.51M 27.26M 27.26M 27.26M 27.13M 27.13M 27.13M
Software Products and Services Growth
1.09% 1.09% 1.09% 0.40% 0.40% 0.40% 6.96% 6.96% 6.96%
Software Contribution
15.99M 15.99M 15.99M 18.18M 18.18M 18.18M 16.37M 16.37M 16.37M 13.66M 13.66M 13.66M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Drug Discovery
12.98M 12.98M 12.98M 7.15M 7.15M 7.15M 9.03M 9.03M 9.03M
Drug Discovery Growth
63.40% 63.40% 63.40% -16.15% -16.15% -16.15% 7.57% 7.57% 7.57%

Drug Discovery Revenue Breakdown
Period Ending Dec 31, 2025Dec 31, 2025Dec 31, 2025Sep 30, 2025Sep 30, 2025Sep 30, 2025Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Drug Discovery Services Customer Contracts
54.76M 54.76M 54.76M 45.32M 45.32M 45.32M 35.12M 35.12M 35.12M 32.69M 32.69M 32.69M 25.14M 25.14M 25.14M 21.97M 21.97M 21.97M 31.88M 31.88M 31.88M 25.61M 25.61M 25.61M
Drug Discovery Services Customer Contracts Growth
117.79% 117.79% 117.79% 106.30% 106.30% 106.30% 10.16% 10.16% 10.16% 27.64% 27.64% 27.64% -54.05% -54.05% -54.05% -62.27% -62.27% -62.27% -44.26% -44.26% -44.26% -57.31% -57.31% -57.31%
Drug Discovery Contribution
1.61M 1.61M 1.61M 1.76M 1.76M 1.76M 1.89M 1.89M 1.89M 2.04M 2.04M 2.04M 2.03M 2.03M 2.03M 2.02M 2.02M 2.02M 2.37M 2.37M 2.37M 2.55M 2.55M 2.55M
Drug Discovery Contribution Growth
-20.78% -20.78% -20.78% -13.29% -13.29% -13.29% -20.12% -20.12% -20.12% -19.95% -19.95% -19.95% -28.03% -28.03% -28.03% -29.72% -29.72% -29.72% -6.89% -6.89% -6.89% 7.24% 7.24% 7.24%

Revenue by Geography
Period Ending Dec 31, 2025Dec 31, 2025Dec 31, 2025Sep 30, 2025Sep 30, 2025Sep 30, 2025Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
United States
152.96M 152.96M 152.96M 131.30M 131.30M 131.30M 124.59M 124.59M 124.59M 121.24M 121.24M 121.24M 114.87M 114.87M 114.87M 133.14M 133.14M 133.14M 141.65M 141.65M 141.65M 134.91M 134.91M 134.91M
United States Growth
33.16% 33.16% 33.16% -1.39% -1.39% -1.39% -12.05% -12.05% -12.05% -10.14% -10.14% -10.14% -29.08% -29.08% -29.08% -8.89% -8.89% -8.89% 0.83% 0.83% 0.83% -6.07% -6.07% -6.07%
EMEA
75.16M 75.16M 75.16M 91.28M 91.28M 91.28M 80.70M 80.70M 80.70M 81.54M 81.54M 81.54M 65.65M 65.65M 65.65M 33.86M 33.86M 33.86M 32.48M 32.48M 32.48M 29.50M 29.50M 29.50M
EMEA Growth
14.49% 14.49% 14.49% 169.56% 169.56% 169.56% 148.50% 148.50% 148.50% 176.37% 176.37% 176.37% 125.33% 125.33% 125.33% 22.28% 22.28% 22.28% 14.51% 14.51% 14.51% 3.03% 3.03% 3.03%
APAC
26.18M 26.18M 26.18M 32.70M 32.70M 32.70M 31.23M 31.23M 31.23M 26.38M 26.38M 26.38M 25.80M 25.80M 25.80M 25.18M 25.18M 25.18M 25.47M 25.47M 25.47M 23.00M 23.00M 23.00M
APAC Growth
1.47% 1.47% 1.47% 29.87% 29.87% 29.87% 22.62% 22.62% 22.62% 14.69% 14.69% 14.69% 5.02% 5.02% 5.02% -19.14% -19.14% -19.14% -16.40% -16.40% -16.40% -15.44% -15.44% -15.44%
Rest of World
1.56M 1.56M 1.56M 1.67M 1.67M 1.67M 1.40M 1.40M 1.40M 1.35M 1.35M 1.35M 1.22M 1.22M 1.22M 1.16M 1.16M 1.16M 1.03M 1.03M 1.03M 1.07M 1.07M 1.07M
Rest of World Growth
28.16% 28.16% 28.16% 44.18% 44.18% 44.18% 35.43% 35.43% 35.43% 25.94% 25.94% 25.94% 21.68% 21.68% 21.68% - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.